Exciting results in the treatment of Prodromal Alzheimer’s Disease (AD)

The Lipididiet project has just released a two year study that reveals a medical food in the form of a daily nutritional drink can help to conserve memory, the ability to think and perform everyday tasks, as well as reduce brain shrinkage in people with Prodromal Alzheimer’s Disease (AD)

Topline results from the European LipiDiDiet clinical trial were presented at the Advances in Alzheimer’s Therapy (AAT) congress as part of a late-breaking presentation.

Read the full press release.

Your contact:
Dr. Claudia Schacht
European Research and Project Office GmbH
Tel.:+49 30 374415-840

Further reading

Tags: FP7